US Asks Supreme Court To Drop Gilead False Claims Case
The US Solicitor General is advising the Supreme Court not to hear a suit challenging whether a False Claims Act suit can be brought if the government knows about the alleged misbehavior and continues to pay for the relevant products or services.
You may also be interested in...
The US Supreme Court announced Monday that it won’t hear a much-watched case that could have limited the government’s ability to bring False Claims Act cases if it knew of the alleged misconduct. Two drug-world patent cases were also declined.
What Did The Government Know, And When Did Know It? US Supreme Court Seeks Views On False-Claims Case
The US Solicitor General was asked to weigh in on Gilead's petition asking the high court to clarify application of its Escobar decision. Trade groups say FDA, not a jury, should decide whether a company has complied with the Food, Drug and Cosmetic Act.
Novartis co-leads industry forum on preapproval access that aims to share best practices and engage patient groups; Janssen is launching three pilots to leverage collection of preapproval access data.